Synapse - Works

Results (115783)

ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and myxoid/round cell liposarcoma [Substudy 3, GSK4427296]

Meeting Abstract

Araujo, D. M.; Ladle, B. H.; He, K.; Powers, B.; McGillivray, A.; Mitrica, I.; Liu, W.; Patel, N.; D'Angelo, S. P.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Subcutaneous epcoritamab + R-DHAX/C in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) eligible for autologous stem cell transplant (ASCT): Preliminary phase 1/2 results

Meeting Abstract

Abrisqueta, P.; Falchi, L.; Phillips, T. J.; De Vos, S.; Nijland, M.; Offner, F.; Bykhovski, I.; Wu, J.; Wang, L.; Rana, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase 1b/2 study of the BET inhibitor ZEN-3694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations

Meeting Abstract

Aftimos, P. G.; Oliveira, M.; Punie, K.; Boni, V.; Hamilton, E. P.; Gucalp, A.; Shah, P. D.; de Miguel, M. J.; Sharma, P.; Bauman, L.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

African American patients with smoldering multiple myeloma may have a lower risk of progression compared to White patients

Meeting Abstract

Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Evaluating serum-free light chain ratio as a biomarker for multiple myeloma

Meeting Abstract

Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Dissecting the interplay of TCR avidity of naive CD8+ T cells and TCR recruitment after antigen exposure by engineering polyclonal repertoires

Meeting Abstract

Straub, A.; Grassmann, S.; Jarosch, S.; Müller, T.; Wagner, K.; Hammel, M.; Buchholz, V.; Schober, K.; Busch, D.
Human Gene Therapy (2022)

Fulltext@MSK | Save

PSMA PET: Guiding metastasis-directed therapy into a new era for oligometastatic prostate cancer

Meeting Abstract

Alberto, M.; Yim, A.; Papa, N.; Siva, S.; Ischia, J.; Touijier, K.; Eastham, J.; Bolton, D.; Perera, M.
International Journal of Urology (2022)

Fulltext@MSK | Save

PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib versus gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma with an FGFR2 gene fusion/rearrangement

Meeting Abstract

Abou-Alfa, G. K.; Borbath, I.; Goyal, L.; Lamarca, A.; Macarulla, T.; Oh, D. Y.; Roychowdhury, S.; Sadeghi, S.; Shroff, R. T.; Li, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

LIO-1: Initial phase 2 experience with lucitanib plus nivolumab in patients with persistent or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO)

Meeting Abstract

Heitz, F.; Oaknin, A.; Backes, F. J.; Van Nieuwenhuysen, E.; Eskander, R. N.; González-Martín, A.; Makker, V.; Marth, C.; Patel, M.; Penson, R. T.; more...
Geburtshilfe und Frauenheilkunde (2022)

Fulltext@MSK | Save

Metastasis in endometriosis: Targeted sequencing suggests non-malignancy associated endometriosis is capable of wide dissemination

Meeting Abstract

Autoren Praetorius, T.; Leonova, A.; Lac, V.; Senz, J.; Tessier-Cloutier, B.; Nazeran, T. M.; Koebel, M.; Grube, M.; Krämer, B.; Yong, P. J.; more...
Geburtshilfe und Frauenheilkunde (2022)

Fulltext@MSK | Save